Literature DB >> 2476992

Transient changes of serum lipoprotein(a) as an acute phase protein.

S Maeda1, A Abe, M Seishima, K Makino, A Noma, M Kawade.   

Abstract

Serum lipoprotein(a) (Lp(a)) was serially determined after acute attacks of myocardial infarction and after surgical operations. Acute phase proteins, such as C-reactive protein, alpha 1-acid glycoprotein, alpha 1-antitrypsin and haptoglobin, increased rapidly and markedly after the episodes. Initial values of serum Lp(a) concentrations were almost the same in both groups. Increases in serum Lp(a) levels were also observed during the first few days, with a return to the initial levels after more than 1 month. The periods for reaching maximal levels of acute phase proteins were similar in both groups of patients. On the contrary, the period required for Lp(a) to reach the maximal level in the myocardial infarction group was significantly longer than in the post-operative group. The present study suggests that Lp(a) has the characteristics of an acute phase reactant and may play an important role in recovery from tissue damage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476992     DOI: 10.1016/0021-9150(89)90218-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  38 in total

1.  Lipoprotein(a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study).

Authors:  Stefano Volpato; Giovanni B Vigna; Mary M McDermott; Margherita Cavalieri; Cinzia Maraldi; Fulvio Lauretani; Stefania Bandinelli; Giovanni Zuliani; Jack M Guralnik; Renato Fellin; Luigi Ferrucci
Journal:  Am J Cardiol       Date:  2010-04-27       Impact factor: 2.778

2.  Changes in Lp(a) lipoprotein levels during the treatment of hypercholesterolaemia with simvastatin.

Authors:  L Slunga; O Johnson; G H Dahlén
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  Low-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomics.

Authors:  Christopher C Imes; Melissa A Austin
Journal:  Biol Res Nurs       Date:  2012-04-23       Impact factor: 2.522

4.  Lipoprotein (a) levels do not influence the outcome of rt-PA therapy in acute myocardial infarction.

Authors:  B Tranchesi; R Santos Filho; C Vinagre; B Caramelli; V Barbosa; O Gebara; G Belloti; F Pileggi; R Maranhão
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

Review 5.  Lipoprotein (a). Heterogeneity and biological relevance.

Authors:  A M Scanu; G M Fless
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

Review 6.  Targeting lipoprotein (a): an evolving therapeutic landscape.

Authors:  Lillian C Man; Erik Kelly; Danielle Duffy
Journal:  Curr Atheroscler Rep       Date:  2015-05       Impact factor: 5.113

7.  Lipoprotein(a) screening in young and middle-aged patients presenting with acute coronary syndrome.

Authors:  Ayman Jubran; Anna Zetser; Barak Zafrir
Journal:  Cardiol J       Date:  2018-09-20       Impact factor: 2.737

8.  Increased concentrations of serum Lp(a) lipoprotein in patients with primary gout.

Authors:  S Takahashi; T Yamamoto; Y Moriwaki; Z Tsutsumi; K Higashino
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

9.  Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.

Authors:  C Sandholzer; E Boerwinkle; N Saha; M C Tong; G Utermann
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

10.  Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction.

Authors:  A D MBewu; P N Durrington; M I Mackness; L Hunt; W H Turkie; J E Creamer
Journal:  Br Heart J       Date:  1994-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.